TreeWAS – Variant ID: rs3809060

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K40.9 Unilateral or unspecified inguinal hernia, without obstruction or gangrene	0.000	0.000	1.000
K44.9 Diaphragmatic hernia without obstruction or gangrene	0.000	0.000	1.000
K40 Inguinal hernia	0.000	0.000	1.000
K40-K46 Hernia	0.000	0.000	1.000
K44 Diaphragmatic hernia	0.000	0.000	1.000
N81.1 Cystocele	0.000	0.006	0.994
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.000	0.015	0.985
N81 Female genital prolapse	0.000	0.016	0.984
N81.4 Uterovaginal prolapse, unspecified	0.000	0.019	0.981
K40.2 Bilateral inguinal hernia, without obstruction or gangrene	0.000	0.022	0.978
K43 Ventral hernia	0.000	0.045	0.955
K41 Femoral hernia	0.000	0.055	0.945
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.000	0.079	0.921
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.114	0.886
N81.9 Female genital prolapse, unspecified	0.000	0.127	0.873
N81.2 Incomplete uterovaginal prolapse	0.000	0.160	0.840
K43.0 Ventral hernia with obstruction, without gangrene	0.000	0.169	0.831
N81.5 Vaginal enterocele	0.000	0.174	0.826
K44.0 Diaphragmatic hernia with obstruction, without gangrene	0.000	0.209	0.791
K40.4 Unilateral or unspecified inguinal hernia, with gangrene	0.000	0.231	0.769
K40.0 Bilateral inguinal hernia, with obstruction, without gangrene	0.000	0.235	0.765
K40.1 Bilateral inguinal hernia, with gangrene	0.000	0.283	0.717
K43.7 Other and unspecified ventral hernia with gangrene	0.000	0.315	0.685
K43.6 Other and unspecified ventral hernia with obstruction, without gangrene	0.000	0.315	0.685
K43.5 Parastomal hernia without obstruction or gangrene	0.000	0.315	0.685
K43.4 Parastomal hernia with gangrene	0.000	0.315	0.685
K43.3 Parastomal hernia with obstruction, without gangrene	0.000	0.315	0.685
K43.2 Incisional hernia without obstruction or gangrene	0.000	0.315	0.685
K43.1 Ventral hernia with gangrene	0.000	0.315	0.685
K41.2 Bilateral femoral hernia, without obstruction or gangrene	0.000	0.322	0.677
K41.1 Bilateral femoral hernia, with gangrene	0.000	0.322	0.677
K41.0 Bilateral femoral hernia, with obstruction, without gangrene	0.000	0.322	0.677
K44.1 Diaphragmatic hernia with gangrene	0.000	0.353	0.646
N81.3 Complete uterovaginal prolapse	0.000	0.354	0.646
K45 Other abdominal hernia	0.000	0.388	0.612
K41.3 Unilateral or unspecified femoral hernia, with obstruction, without gangrene	0.000	0.392	0.608
K46 Unspecified abdominal hernia	0.000	0.395	0.605
N81.6 Rectocele	0.000	0.402	0.598
K41.4 Unilateral or unspecified femoral hernia, with gangrene	0.000	0.405	0.595
K42 Umbilical hernia	0.000	0.434	0.566
N81.0 Female urethrocele	0.000	0.522	0.478
N81.8 Other female genital prolapse	0.000	0.531	0.469
K42.9 Umbilical hernia without obstruction or gangrene	0.000	0.556	0.444
K45.1 Other specified abdominal hernia with gangrene	0.000	0.561	0.439
K46.1 Unspecified abdominal hernia with gangrene	0.000	0.566	0.434
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.000	0.576	0.424
K45.8 Other specified abdominal hernia without obstruction or gangrene	0.000	0.586	0.413
K42.1 Umbilical hernia with gangrene	0.000	0.594	0.406
K45.0 Other specified abdominal hernia with obstruction, without gangrene	0.000	0.629	0.370
K46.0 Unspecified abdominal hernia with obstruction, without gangrene	0.000	0.662	0.337
D17.6 Benign lipomatous neoplasm of spermatic cord	0.000	0.671	0.329
K42.0 Umbilical hernia with obstruction, without gangrene	0.000	0.843	0.157
D25.9 Leiomyoma of uterus, unspecified	0.093	0.907	0.000
D25 Leiomyoma of uterus	0.076	0.924	0.000
D25.1 Intramural leiomyoma of uterus	0.072	0.928	0.000
D25.2 Subserosal leiomyoma of uterus	0.070	0.930	0.000
I10 Essential (primary) hypertension	0.049	0.951	0.000
S02.10 Fracture of base of skull (closed)	0.042	0.958	0.000
S02.1 Fracture of base of skull	0.041	0.959	0.000
S02 Fracture of skull and facial bones	0.040	0.960	0.000
S02.4 Fracture of malar and maxillary bones	0.040	0.960	0.000
S02.40 Fracture of malar and maxillary bones (closed)	0.039	0.961	0.000
S02.3 Fracture of orbital floor	0.035	0.965	0.000
S02.6 Fracture of mandible	0.034	0.966	0.000
S02.8 Fractures of other skull and facial bones	0.033	0.967	0.000
S02.7 Multiple fractures involving skull and facial bones	0.032	0.968	0.000
S02.11 Fracture of base of skull (open)	0.032	0.968	0.000
S02.30 Fracture of orbital floor (closed)	0.032	0.968	0.000
S02.5 Fracture of tooth	0.031	0.969	0.000
S02.60 Fracture of mandible (closed)	0.030	0.970	0.000
S02.41 Fracture of malar and maxillary bones (open)	0.029	0.971	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.028	0.972	0.000
S82.30 Fracture of lower end of tibia (closed)	0.000	0.973	0.027
S02.70 Multiple fractures involving skull and facial bones (closed)	0.026	0.974	0.000
S02.2 Fracture of nasal bones	0.026	0.974	0.000
S02.0 Fracture of vault of skull	0.026	0.974	0.000
S02.31 Fracture of orbital floor (open)	0.025	0.974	0.000
S02.9 Fracture of skull and facial bones, part unspecified	0.025	0.975	0.000
S02.61 Fracture of mandible (open)	0.025	0.975	0.000
S02.81 Fractures of other skull and facial bones (open)	0.024	0.976	0.000
S02.50 Fracture of tooth (closed)	0.024	0.976	0.000
S02.71 Multiple fractures involving skull and facial bones (open)	0.023	0.977	0.000
S02.51 Fracture of tooth (open)	0.022	0.977	0.000
S02.21 Fracture of nasal bones (open)	0.020	0.979	0.000
S02.01 Fracture of vault of skull (open)	0.019	0.981	0.000
S02.91 Fracture of skull and facial bones, part unspecified (open)	0.018	0.981	0.000
S02.00 Fracture of vault of skull (closed)	0.016	0.984	0.000
S02.90 Fracture of skull and facial bones, part unspecified (closed)	0.014	0.985	0.000
D25.0 Submucous leiomyoma of uterus	0.014	0.986	0.000
S02.20 Fracture of nasal bones (closed)	0.014	0.986	0.000
J43.9 Emphysema, unspecified	0.011	0.989	0.000
S82.3 Fracture of lower end of tibia	0.000	0.991	0.009
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.009	0.991	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.992	0.008
T36.0 Penicillins	0.008	0.992	0.000
T36 Poisoning by systemic antibiotics	0.008	0.992	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.008	0.992	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.007	0.993	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.007	0.993	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.007	0.993	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
I86.4 Gastric varices	0.000	0.993	0.007
I86.8 Varicose veins of other specified sites	0.000	0.993	0.007
T38.1 Thyroid hormones and substitutes	0.007	0.993	0.000
T50.8 Diagnostic agents	0.007	0.993	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.993	0.000
T50.1 Loop [high-ceiling] diuretics	0.006	0.994	0.000
S05 Injury of eye and orbit	0.006	0.994	0.000
T50.4 Drugs affecting uric acid metabolism	0.006	0.994	0.000
S00-S09 Injuries to the head	0.006	0.994	0.000
J43 Emphysema	0.006	0.994	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.006	0.994	0.000
I86 Varicose veins of other sites	0.000	0.994	0.006
T36.3 Macrolides	0.006	0.994	0.000
N28.8 Other specified disorders of kidney and ureter	0.006	0.994	0.000
T36.4 Tetracyclines	0.006	0.994	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.006	0.994	0.000
S05.3 Ocular laceration without prolapse or loss of intraocular tissue	0.006	0.994	0.000
T36.9 Systemic antibiotic, unspecified	0.006	0.994	0.000
T36.8 Other systemic antibiotics	0.006	0.994	0.000
T36.7 Antifungal antibiotics, systemically used	0.006	0.994	0.000
T36.6 Rifamycins	0.006	0.994	0.000
T36.5 Aminoglycosides	0.006	0.994	0.000
T36.2 Chloramphenicol group	0.006	0.994	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.006	0.994	0.000
T40.6 Other and unspecified narcotics	0.006	0.994	0.000
I86.2 Pelvic varices	0.000	0.994	0.006
S05.1 Contusion of eyeball and orbital tissues	0.006	0.994	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.006	0.994	0.000
S82.31 Fracture of lower end of tibia (open)	0.000	0.994	0.006
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.006	0.994	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.006	0.994	0.000
T43.9 Psychotropic drug, unspecified	0.006	0.994	0.000
S06 Intracranial injury	0.006	0.994	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.006	0.994	0.000
H35.0 Background retinopathy and retinal vascular changes	0.000	0.994	0.006
T42.3 Barbiturates	0.006	0.994	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.006	0.994	0.000
J43.8 Other emphysema	0.006	0.994	0.000
S05.5 Penetrating wound of eyeball with foreign body	0.006	0.994	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.005	0.994	0.000
T42.2 Succinimides and oxazolidinediones	0.005	0.994	0.000
T38.9 Other and unspecified hormone antagonists	0.005	0.994	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.994	0.000
T38.7 Androgens and anabolic congeners	0.005	0.994	0.000
T38.5 Other oestrogens and progestogens	0.005	0.994	0.000
T38.4 Oral contraceptives	0.005	0.994	0.000
T38.2 Antithyroid drugs	0.005	0.994	0.000
T38.0 Glucocorticoids and synthetic analogues	0.005	0.994	0.000
T50.7 Analeptics and opioid receptor antagonists	0.005	0.994	0.000
T50.5 Appetite depressants	0.005	0.994	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.994	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.994	0.000
T43.6 Psychostimulants with abuse potential	0.005	0.995	0.000
S06.2 Diffuse brain injury	0.005	0.995	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.005	0.995	0.000
M25.74 Osteophyte (Hand)	0.005	0.995	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue	0.005	0.995	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.005	0.995	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.000	0.995	0.005
Z98.1 Arthrodesis status	0.005	0.995	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.005	0.995	0.000
T42.0 Hydantoin derivatives	0.005	0.995	0.000
X58.9 Unspecified place	0.005	0.995	0.000
S06.8 Other intracranial injuries	0.005	0.995	0.000
T47.4 Other laxatives	0.005	0.995	0.000
T47.6 Antidiarrhoeal drugs	0.005	0.995	0.000
S05.7 Avulsion of eye	0.005	0.995	0.000
S05.4 Penetrating wound of orbit with or without foreign body	0.005	0.995	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.005	0.995	0.000
J34.3 Hypertrophy of nasal turbinates	0.005	0.995	0.000
T40.3 Methadone	0.005	0.995	0.000
S08 Traumatic amputation of part of head	0.005	0.995	0.000
S07 Crushing injury of head	0.005	0.995	0.000
S04 Injury of cranial nerves	0.005	0.995	0.000
I10-I15 Hypertensive diseases	0.005	0.995	0.000
J43.1 Panlobular emphysema	0.005	0.995	0.000
J43.0 MacLeod's syndrome	0.005	0.995	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.005	0.995	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
T47.7 Emetics	0.005	0.995	0.000
T47.5 Digestants	0.005	0.995	0.000
T47.3 Saline and osmotic laxatives	0.005	0.995	0.000
T47.2 Stimulant laxatives	0.005	0.995	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.005	0.995	0.000
T42.4 Benzodiazepines	0.005	0.995	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
S05.6 Penetrating wound of eyeball without foreign body	0.005	0.995	0.000
I86.3 Vulval varices	0.000	0.995	0.005
I86.0 Sublingual varices	0.000	0.995	0.005
S05.8 Other injuries of eye and orbit	0.005	0.995	0.000
S06.4 Epidural haemorrhage	0.005	0.995	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
J43.2 Centrilobular emphysema	0.005	0.995	0.000
T40.1 Heroin	0.005	0.995	0.000
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body	0.005	0.995	0.000
S06.9 Intracranial injury, unspecified	0.005	0.995	0.000
S06.3 Focal brain injury	0.005	0.995	0.000
T47.0 Histamine H(2)-receptor antagonists	0.005	0.995	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.995	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.995	0.000
T46.7 Peripheral vasodilators	0.004	0.995	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.995	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.995	0.000
T48.4 Expectorants	0.004	0.995	0.000
T48.3 Antitussives	0.004	0.995	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.004	0.995	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.995	0.000
T48.0 Oxytocic drugs	0.004	0.995	0.000
S03 Dislocation, sprain and strain of joints and ligaments of head	0.005	0.995	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.004	0.995	0.000
T40.8 Lysergide [LSD]	0.004	0.995	0.000
T40.7 Cannabis (derivatives)	0.004	0.995	0.000
T40.0 Opium	0.004	0.995	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.995	0.000
T48.5 Anti-common-cold drugs	0.004	0.995	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
T42.1 Iminostilbenes	0.004	0.995	0.000
H18.5 Hereditary corneal dystrophies	0.005	0.995	0.000
T40.5 Cocaine	0.004	0.995	0.000
T46.1 Calcium-channel blockers	0.004	0.996	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.004	0.996	0.000
I42.2 Other hypertrophic cardiomyopathy	0.000	0.996	0.004
S06.7 Intracranial injury with prolonged coma	0.004	0.996	0.000
T41.5 Therapeutic gases	0.004	0.996	0.000
T41.4 Anaesthetic, unspecified	0.004	0.996	0.000
T41.3 Local anaesthetics	0.004	0.996	0.000
T41.2 Other and unspecified general anaesthetics	0.004	0.996	0.000
T41.1 Intravenous anaesthetics	0.004	0.996	0.000
T41.0 Inhaled anaesthetics	0.004	0.996	0.000
T49.9 Topical agent, unspecified	0.004	0.996	0.000
T49.8 Other topical agents	0.004	0.996	0.000
T49.7 Dental drugs, topically applied	0.004	0.996	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
T49.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
T49.3 Emollients, demulcents and protectants	0.004	0.996	0.000
T49.2 Local astringents and local detergents	0.004	0.996	0.000
T49.1 Antipruritics	0.004	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
M79.62 Pain in limb (Upper arm)	0.000	0.996	0.004
H18.9 Disorder of cornea, unspecified	0.004	0.996	0.000
T40.4 Other synthetic narcotics	0.004	0.996	0.000
S06.1 Traumatic cerebral oedema	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
H18 Other disorders of cornea	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
S06.21 Diffuse brain injury (with open intracranial wound)	0.004	0.996	0.000
S06.40 Epidural haemorrhage (without open intracranial wound)	0.004	0.996	0.000
H18.6 Keratoconus	0.004	0.996	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
T37.5 Antiviral drugs	0.004	0.996	0.000
T37.4 Anthelminthics	0.004	0.996	0.000
T37.3 Other antiprotozoal drugs	0.004	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
T37.1 Antimycobacterial drugs	0.004	0.996	0.000
T37.0 Sulphonamides	0.004	0.996	0.000
S06.5 Traumatic subdural haemorrhage	0.004	0.996	0.000
G47.3 Sleep apnoea	0.004	0.996	0.000
H18.2 Other corneal oedema	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.004	0.996	0.000
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.004	0.996	0.000
S06.81 Other intracranial injuries (with open intracranial wound)	0.004	0.996	0.000
G47.9 Sleep disorder, unspecified	0.004	0.996	0.000
S06.6 Traumatic subarachnoid haemorrhage	0.004	0.996	0.000
R85.5 Abnormal microbiological findings	0.000	0.996	0.004
T43.2 Other and unspecified antidepressants	0.004	0.996	0.000
S04.9 Injury of unspecified cranial nerve	0.004	0.996	0.000
S04.8 Injury of other cranial nerves	0.004	0.996	0.000
S04.7 Injury of accessory nerve	0.004	0.996	0.000
S04.6 Injury of acoustic nerve	0.004	0.996	0.000
S04.5 Injury of facial nerve	0.004	0.996	0.000
S04.4 Injury of abducent nerve	0.004	0.996	0.000
S04.3 Injury of trigeminal nerve	0.004	0.996	0.000
S04.2 Injury of trochlear nerve	0.004	0.996	0.000
S04.1 Injury of oculomotor nerve	0.004	0.996	0.000
S04.0 Injury of optic nerve and pathways	0.004	0.996	0.000
S07.9 Crushing injury of head, part unspecified	0.004	0.996	0.000
S07.8 Crushing injury of other parts of head	0.004	0.996	0.000
S07.1 Crushing injury of skull	0.004	0.996	0.000
S07.0 Crushing injury of face	0.004	0.996	0.000
S08.9 Traumatic amputation of unspecified part of head	0.004	0.996	0.000
S08.8 Traumatic amputation of other parts of head	0.004	0.996	0.000
S08.1 Traumatic amputation of ear	0.004	0.996	0.000
S08.0 Avulsion of scalp	0.004	0.996	0.000
I13 Hypertensive heart and renal disease	0.004	0.996	0.000
S05.9 Injury of eye and orbit, part unspecified	0.003	0.996	0.000
S06.0 Concussion	0.004	0.996	0.000
S06.41 Epidural haemorrhage (with open intracranial wound)	0.004	0.996	0.000
S06.31 Focal brain injury (with open intracranial wound)	0.003	0.996	0.000
S06.91 Intracranial injury, unspecified (with open intracranial wound)	0.003	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
S03.5 Sprain and strain of joints and ligaments of other and unspecified parts of head	0.003	0.996	0.000
S03.4 Sprain and strain of jaw	0.003	0.996	0.000
S03.3 Dislocation of other and unspecified parts of head	0.003	0.996	0.000
S03.1 Dislocation of septal cartilage of nose	0.003	0.996	0.000
S03.0 Dislocation of jaw	0.003	0.996	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.996	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.996	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.996	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.996	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.996	0.000
T44.0 Anticholinesterase agents	0.003	0.996	0.000
H18.3 Changes in corneal membranes	0.003	0.996	0.000
I85.9 Oesophageal varices without bleeding	0.000	0.997	0.003
I86.1 Scrotal varices	0.000	0.997	0.003
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)	0.003	0.997	0.000
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
S03.2 Dislocation of tooth	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
K26.3 Acute without haemorrhage or perforation	0.003	0.997	0.000
S06.11 Traumatic cerebral oedema (with open intracranial wound)	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
I85 Oesophageal varices	0.000	0.997	0.003
H18.7 Other corneal deformities	0.003	0.997	0.000
K72.9 Hepatic failure, unspecified	0.000	0.997	0.003
I85.0 Oesophageal varices with bleeding	0.000	0.997	0.003
T43.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
D37.6 Liver, gallbladder and bile ducts	0.000	0.997	0.003
H35.4 Peripheral retinal degeneration	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
H35.2 Other proliferative retinopathy	0.000	0.997	0.003
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.003	0.997	0.000
H18.4 Corneal degeneration	0.003	0.997	0.000
H35 Other retinal disorders	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
S06.10 Traumatic cerebral oedema (without open intracranial wound)	0.003	0.997	0.000
Z63.0 Problems in relationship with spouse or partner	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
H35.9 Retinal disorder, unspecified	0.000	0.997	0.003
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.003	0.997	0.000
H18.8 Other specified disorders of cornea	0.003	0.997	0.000
H18.0 Corneal pigmentations and deposits	0.003	0.997	0.000
X58 Exposure to other specified factors	0.003	0.997	0.000
I13.9 Hypertensive heart and renal disease, unspecified	0.003	0.997	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.003	0.997	0.000
I13.1 Hypertensive heart and renal disease with renal failure	0.003	0.997	0.000
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.003	0.997	0.000
G47 Sleep disorders	0.003	0.997	0.000
S06.01 Concussion (with open intracranial wound)	0.003	0.997	0.000
H18.1 Bullous keratopathy	0.003	0.997	0.000
H35.5 Hereditary retinal dystrophy	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.000	0.997	0.003
I80 Phlebitis and thrombophlebitis	0.000	0.997	0.003
D37.7 Other digestive organs	0.000	0.997	0.003
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T45.5 Anticoagulants	0.003	0.997	0.000
I11 Hypertensive heart disease	0.003	0.997	0.000
G47.0 Disorders of initiating and maintaining sleep [insomnias]	0.003	0.997	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.997	0.003
C48.2 Peritoneum, unspecified	0.000	0.997	0.003
Z63.7 Other stressful life events affecting family and household	0.003	0.997	0.000
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.000	0.997	0.003
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.000	0.997	0.003
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.003	0.997	0.000
I15 Secondary hypertension	0.002	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.997	0.000
J82 Pulmonary eosinophilia, not elsewhere classified	0.003	0.997	0.000
Q60.0 Renal agenesis, unilateral	0.000	0.997	0.002
H35.1 Retinopathy of prematurity	0.000	0.997	0.002
I89.1 Lymphangitis	0.000	0.997	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.997	0.000
G61.8 Other inflammatory polyneuropathies	0.002	0.998	0.000
Q51.3 Bicornate uterus	0.000	0.998	0.002
X58.8 Other specified place	0.002	0.998	0.000
X58.0 Home	0.002	0.998	0.000
X58.7 Farm	0.002	0.998	0.000
X58.6 Industrial and construction area	0.002	0.998	0.000
X58.5 Trade and service area	0.002	0.998	0.000
X58.4 Street and highway	0.002	0.998	0.000
X58.2 School, other institution and public administrative area	0.002	0.998	0.000
X58.1 Residential institution	0.002	0.998	0.000
R85 Abnormal findings in specimens from digestive organs and abdominal cavity	0.000	0.998	0.002
X58.3 Sports and athletics area	0.002	0.998	0.000
Q61.3 Polycystic kidney, unspecified	0.002	0.998	0.000
H35.7 Separation of retinal layers	0.000	0.998	0.002
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.000	0.998	0.002
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.000	0.998	0.002
I88 Nonspecific lymphadenitis	0.000	0.998	0.002
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.002	0.998	0.000
G47.4 Narcolepsy and cataplexy	0.002	0.998	0.000
E11.2 With renal complications	0.000	0.998	0.002
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.998	0.002
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
I88.9 Nonspecific lymphadenitis, unspecified	0.000	0.998	0.002
I89.0 Lymphoedema, not elsewhere classified	0.000	0.998	0.002
R85.8 Other abnormal findings	0.000	0.998	0.002
S09 Other and unspecified injuries of head	0.002	0.998	0.000
D37.5 Rectum	0.000	0.998	0.002
I15.8 Other secondary hypertension	0.002	0.998	0.000
Q63.0 Accessory kidney	0.002	0.998	0.000
Q61 Cystic kidney disease	0.002	0.998	0.000
Q63 Other congenital malformations of kidney	0.002	0.998	0.000
S06.00 Concussion (without open intracranial wound)	0.002	0.998	0.000
G47.2 Disorders of the sleep-wake schedule	0.002	0.998	0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.000	0.998	0.002
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.000	0.998	0.002
Q61.2 Polycystic kidney, adult type	0.002	0.998	0.000
Q63.1 Lobulated, fused and horseshoe kidney	0.002	0.998	0.000
M89.03 Algoneurodystrophy (Forearm)	0.002	0.998	0.000
I80.9 Phlebitis and thrombophlebitis of unspecified site	0.000	0.998	0.002
I15.2 Hypertension secondary to endocrine disorders	0.002	0.998	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.002	0.998	0.000
M89.0 Algoneurodystrophy	0.002	0.998	0.000
Q61.0 Congenital single renal cyst	0.002	0.998	0.000
R85.9 Unspecified abnormal finding	0.000	0.998	0.002
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
I88.0 Nonspecific mesenteric lymphadenitis	0.000	0.998	0.002
T63.4 Venom of other arthropods	0.002	0.998	0.000
J81 Pulmonary oedema	0.002	0.998	0.000
E80.4 Gilbert's syndrome	0.002	0.998	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.002	0.998	0.000
J12.9 Viral pneumonia, unspecified	0.002	0.998	0.000
J84.8 Other specified interstitial pulmonary diseases	0.002	0.998	0.000
T93.2 Sequelae of other fractures of lower limb	0.000	0.998	0.002
D37.2 Small intestine	0.000	0.998	0.002
Q61.4 Renal dysplasia	0.002	0.998	0.000
S09.2 Traumatic rupture of ear drum	0.002	0.998	0.000
W18.3 Sports and athletics area	0.002	0.998	0.000
X58.01 Exposure to other specified factors: Home: While engaged in leisure activity	0.002	0.998	0.000
X58.89 Exposure to other specified factors: Other specified places: During unspecified activity	0.002	0.998	0.000
R85.6 Abnormal cytological findings	0.000	0.998	0.002
R85.4 Abnormal immunological findings	0.000	0.998	0.002
R85.3 Abnormal level of substances chiefly nonmedicinal as to source	0.000	0.998	0.002
R85.2 Abnormal level of other drugs, medicaments and biological substances	0.000	0.998	0.002
R85.1 Abnormal level of hormones	0.000	0.998	0.002
R85.0 Abnormal level of enzymes	0.000	0.998	0.002
J80-J84 Other respiratory diseases principally affecting the interstitium	0.002	0.998	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
T39.0 Salicylates	0.002	0.998	0.000
Z63 Other problems related to primary support group, including family circumstances	0.002	0.998	0.000
M89.55 Osteolysis (Pelvic region and thigh)	0.002	0.998	0.000
G47.8 Other sleep disorders	0.002	0.998	0.000
G47.1 Disorders of excessive somnolence [hypersomnias]	0.002	0.998	0.000
H66.9 Otitis media, unspecified	0.000	0.998	0.002
I88.1 Chronic lymphadenitis, except mesenteric	0.000	0.998	0.002
D37.4 Colon	0.000	0.998	0.002
M54.49 Lumbago with sciatica (Site unspecified)	0.000	0.998	0.002
Z98.2 Presence of cerebrospinal fluid drainage device	0.000	0.998	0.002
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
Q63.2 Ectopic kidney	0.002	0.998	0.000
R85.7 Abnormal histological findings	0.000	0.998	0.002
I12 Hypertensive renal disease	0.002	0.998	0.000
D37.3 Appendix	0.000	0.998	0.002
Q63.9 Congenital malformation of kidney, unspecified	0.002	0.998	0.000
S09.7 Multiple injuries of head	0.002	0.998	0.000
S09.1 Injury of muscle and tendon of head	0.002	0.998	0.000
T40.2 Other opioids	0.002	0.998	0.000
J80 Adult respiratory distress syndrome	0.002	0.998	0.000
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.000	0.998	0.002
X23.0 Home	0.002	0.998	0.000
I15.9 Seconday hypertension, unspecified	0.002	0.998	0.000
I15.0 Renovascular hypertension	0.002	0.998	0.000
Q61.8 Other cystic kidney diseases	0.002	0.998	0.000
Q61.1 Polycystic kidney, infantile type	0.002	0.998	0.000
K86.1 Other chronic pancreatitis	0.000	0.998	0.002
Q51.2 Other doubling of uterus	0.000	0.998	0.002
Q63.8 Other specified congenital malformations of kidney	0.002	0.998	0.000
Q63.3 Hyperplastic and giant kidney	0.002	0.998	0.000
X23.9 Unspecified place	0.002	0.998	0.000
Z63.4 Disappearance and death of family member	0.002	0.998	0.000
D37.9 Digestive organ, unspecified	0.000	0.998	0.002
M89.08 Algoneurodystrophy (Other)	0.002	0.998	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.002	0.998	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.002	0.998	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.002	0.998	0.000
S62.61 Fracture of other finger (open)	0.002	0.998	0.000
G24.9 Dystonia, unspecified	0.002	0.998	0.000
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.998	0.002
Q60 Renal agenesis and other reduction defects of kidney	0.001	0.998	0.001
E04.1 Non-toxic single thyroid nodule	0.000	0.998	0.002
W18.5 Trade and service area	0.002	0.998	0.000
I88.8 Other nonspecific lymphadenitis	0.000	0.998	0.001
Q51 Congenital malformations of uterus and cervix	0.000	0.998	0.002
Q60-Q64 Congenital malformations of the urinary system	0.002	0.998	0.000
M54.4 Lumbago with sciatica	0.000	0.998	0.002
J84 Other interstitial pulmonary diseases	0.002	0.998	0.000
D47.2 Monoclonal gammopathy	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations